Inventor · disambiguated record
Maurizio Botta
Also filed as: BOTTA MAURIZIO
14 granted patents·5 pending applications·18 citations·filing 2003–2020
84Inventor score
Files withAZIENDA OSPEDALIERA UNIV SENESE3BIAVA MARIANGELA2BOTTA MAURIZIO2LEAD DISCOVERY SIENA S R L2UNIV DEGLI STUDI DI SIENA2
Top patents by PatentIndex Score
19 records- 0177US7589086B2Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agentsUNIV SIENA·Filed 2004·Granted Sep 15, 2009·17 cites·14 claims
- 0256US8685953B2Linear and cyclic guanidine derivatives, method of preparation and uses thereofBOTTA MAURIZIO·Filed 2009·Granted Apr 1, 2014·1 cites·9 claims
- 0346US2010311734A1Spiro Compounds Useful as Antagonists of the H1 ReceptorGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 0444US10941121B2Human helicase DDX3 inhibitors as therapeutic agentsAZIENDA OSPEDALIERA UNIV SENESE·Filed 2020·Granted Mar 9, 2021·0 cites·11 claims
- 0544US7910581B2Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereofBIAVA MARIANGELA·Filed 2006·Granted Mar 22, 2011·0 cites·16 claims
- 0643US11814366B2Antiviral compounds and use thereofUNIV DEGLI STUDI DI SIENA·Filed 2019·Granted Nov 14, 2023·0 cites·11 claims
- 0741US8304410B2Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates theretoBIAVA MARIANGELA·Filed 2008·Granted Nov 6, 2012·0 cites·5 claims
- 0840US8895600B2Non peptidic 14-3-3 inhibitors and the use thereofBOTTA MAURIZIO·Filed 2012·Granted Nov 25, 2014·0 cites·3 claims
- 0939US10093642B2Multitarget hedgehog pathway inhibitors and uses thereofUNIV DEGLI STUDI DI SIENA·Filed 2014·Granted Oct 9, 2018·0 cites·6 claims
- 1038US8012970B2Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis process and uses thereofUNIVERSTA DEGLI STUDI DI SIENA·Filed 2011·Granted Sep 6, 2011·0 cites·22 claims
- 1137US7368605B2Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activitySIGMA TAU IND FARMACEUTI·Filed 2003·Granted May 6, 2008·0 cites·10 claims
- 1233US2018016243A1Human helicase ddx3 inhibitors as therapeutic agentsAZIENDA OSPEDALIERA UNIV SENESE·Filed 2016·Application pending·0 cites
- 1332US8466164B24-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereofSCHENONE SILVIA·Filed 2008·Granted Jun 18, 2013·0 cites·3 claims
- 1431US2010292260A16-vinyl pyrimidine and pyrimidinone derivatives and the use thereofUNI DEGLI STUDI DE SIENA·Filed 2006·Application pending·0 cites
- 1530US11000512B2Use of DDX3 inhibitors as antiproliferative agentsAZIENDA OSPEDALIERA UNIV SENESE·Filed 2017·Granted May 11, 2021·0 cites·20 claims
- 1625US10071975B2Macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitorsCYGNET BIOSCIENCES B V·Filed 2014·Granted Sep 11, 2018·0 cites·21 claims
- 1725US10004702B2Linear guanidine derivatives, methods of preparation and uses thereofLEAD DISCOVERY SIENA S R L·Filed 2015·Granted Jun 26, 2018·0 cites·20 claims
- 1824US2012202814A1Compounds with ddx3 inhibitory activity and uses thereofRADI MARCO·Filed 2010·Application pending·0 cites
- 1918US2018186796A1Compounds and uses thereofLEAD DISCOVERY SIENA S R L·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maurizio Botta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →